Oruka Therapeutics Ownership | Who Owns Oruka Therapeutics?
Oruka Therapeutics Ownership Summary
Oruka Therapeutics is owned by 122.04% institutional investors, 1.23% insiders. Fmr is the largest institutional shareholder, holding 16.14% of ORKA shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 2.87% of its assets in Oruka Therapeutics shares.
ORKA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Oruka Therapeutics | 122.04% | 1.23% | -23.27% |
| Sector | Healthcare Stocks | 129.28% | 12.06% | -41.34% |
| Industry | Biotech Stocks | 181.42% | 11.67% | -93.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 10.15M | 16.14% | $845.30M |
| Blackrock funding, inc. /de | 5.21M | 8.29% | $433.96M |
| Vr adviser | 4.15M | 7.52% | $394.81M |
| Fairmount funds management | 3.71M | 6.72% | $352.63M |
| Rtw investments, lp | 3.14M | 5.69% | $298.74M |
| Vanguard group | 2.45M | 5.57% | $74.37M |
| Capital world investors | 3.43M | 5.45% | $285.61M |
| State street | 2.82M | 4.48% | $234.62M |
| Vanguard capital management | 2.64M | 4.21% | $220.24M |
| Paradigm biocapital advisors lp | 2.14M | 3.89% | $204.09M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Remedium capital partners | 954.15K | 29.05% | $79.47M |
| Fairmount funds management | 3.71M | 23.31% | $352.63M |
| Vr adviser | 4.15M | 11.97% | $394.81M |
| Avidity partners management lp | 760.42K | 11.59% | $72.37M |
| Paradigm biocapital advisors lp | 2.14M | 3.82% | $204.09M |
| B group | 75.00K | 3.35% | $7.14M |
| Bellevue group | 1.66M | 3.32% | $157.71M |
| Great point partners | 183.33K | 3.30% | $17.45M |
| Sio capital management | 177.12K | 2.79% | $16.86M |
| Deep track capital, lp | 1.93M | 2.67% | $183.30M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 1.55M | 1.29% | 1.55M |
| Bellevue group | 1.66M | 3.32% | 1.15M |
| T. rowe price investment management | 1.10M | 0.07% | 1.10M |
| Fmr | 10.15M | 0.04% | 1.09M |
| Rtw investments, lp | 3.14M | 2.55% | 1.08M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Commodore capital lp | - | - | -1.75M |
| Avoro capital advisors | - | - | -1.33M |
| Viking global investors lp | 1.50M | 0.41% | -1.16M |
| Mercer global advisors inc /adv | 1.08K | 0.00% | -801.39K |
| Bnp paribas arbitrage, snc | 459.53K | 0.01% | -619.49K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 1.55M | 1.29% | 1.55M | $147.95M |
| T. rowe price investment management | 1.10M | 0.07% | 1.10M | $105.04M |
| Summit partners public asset management | 658.30K | 1.10% | 658.30K | $62.65M |
| Macquarie management | 219.04K | 0.03% | 219.04K | $20.85M |
| First turn management | 155.34K | 1.58% | 155.34K | $14.78M |
Sold Out
| Holder | Change |
|---|---|
| Mai capital management | -1.00 |
| National bank of canada /fi/ | -5.00 |
| Ares financial consulting | -7.00 |
| Ameritas advisory services | -11.00 |
| Key capital management | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 268 | 0.37% | 76,729,295 | 2.89% | 122 | 0.87% | 161 | -18.27% | 78 | 62.50% |
| Jun 30, 2026 | 263 | 40.64% | 74,518,416 | 43.25% | 135 | 1.52% | 195 | 54.76% | 47 | 46.88% |
| Mar 31, 2026 | 182 | 26.39% | 52,177,550 | -1.28% | 114 | 0.80% | 125 | 25.00% | 30 | 87.50% |
| Dec 31, 2025 | 62 | -43.12% | 11,958,114 | -73.75% | 27 | 0.23% | 45 | -28.57% | 4 | -82.61% |
| Sep 30, 2025 | 42 | -48.15% | 6,253,192 | -81.84% | 14 | 0.22% | 25 | -51.92% | 9 | -35.71% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 1.90M | 2.87% | 172.06K |
| Vanguard Morn Total Stk Mkt Idx Investor | 1.73M | 2.86% | 5.92K |
| Vanguard Total Stock Mkt Idx Inv | 1.73M | 2.86% | 5.92K |
| Fidelity Growth Compy Commingled Pl S | 1.70M | 2.81% | 54.10K |
| State Street® SPDR® S&P® Biotech ETF | 1.73M | 2.62% | 45.19K |
| American Funds SMALLCAP World A | 1.53M | 2.31% | - |
| Capital Group New Economy Comp | 1.32M | 2.19% | 1.32M |
| American Funds New Economy A | 1.32M | 2.00% | - |
| Fidelity Growth Company Fund | 1.29M | 1.95% | - |
| iShares Russell 2000 ETF | 1.28M | 1.93% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 16, 2026 | Goncalves Joana | Chief Medical Officer | Sell | $192.90K |
| Nov 16, 2026 | Goncalves Joana | Chief Medical Officer | Sell | $30.74K |
| Nov 16, 2026 | Goncalves Joana | Chief Medical Officer | Sell | $258.74K |
| Nov 16, 2026 | Goncalves Joana | Chief Medical Officer | Sell | $150.72K |
| Nov 16, 2026 | Goncalves Joana | Chief Medical Officer | Sell | $20.67K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 40 |
| 2026 Q3 | - | 50 |
| 2026 Q2 | - | 34 |
| 2026 Q1 | - | 17 |
| 2025 Q4 | - | 4 |
ORKA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools